As my recent post documented, SUD treatment is both effective for patients and has large, positive spillovers to society. So why is it underfunded and underprovided? In my latest AcademyHealth post, I offer some answers.
As my recent post documented, SUD treatment is both effective for patients and has large, positive spillovers to society. So why is it underfunded and underprovided? In my latest AcademyHealth post, I offer some answers.
Austin Frakt, PhD, is co-Editor-in-Chief of The Incidental Economist. His day job is Associate Director of the Partnered Evidence-based Policy Resource Center at the Boston VA Healthcare System, U.S. Department of Veterans Affairs. He is also a Principal Research Scientist with the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health, and Editor-in-Chief of the journal Health Services Research.
Austin Frakt, PhD, is co-Editor-in-Chief of The Incidental Economist. His day job is Associate Director of the Partnered Evidence-based Policy Resource Center at the Boston VA Healthcare System, U.S. Department of Veterans Affairs. He is also a Principal Research Scientist with the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health, and Editor-in-Chief of the journal Health Services Research.
Work posted here under copyright © of the authors • Details on the Site Policies page